Mutational characteristics of extranodal NK/T-cell lymphoma analyzed in relation to clinical prognostic indices
Annals of Hematology · 2024
DOI: 10.1007/s00277-024-06035-w ↗Kurz gefasst
Fachartikel in der Zeitschrift Annals of Hematology, 2024. Verfasst von Jiyeon Lee und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, #81, Irown-ro, Gangnam-gu, Seoul, 06351, Korea. Hauptthemen laut MEDLINE: Lymphoma, Extranodal NK-T-Cell, Mutation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Extranodal NK/T-cell lymphoma (ENKTL) is a malignant lymphoma that is associated with Epstein-Barr virus (EBV) infection and poor prognosis. Several clinical risk stratification tools for ENKTL patients have been developed; however, their relationship with molecular alterations of tumor is unclear. We performed panel-based next generation sequencing (NGS) on formalin-fixed paraffin-embedded tissue of 40 ENKTL patients and analyzed them with the clinicopathological features. Patients with over 60 years of age, non-nasal type, stage III-IV, and distant lymph node involvement were 14 (35.0%), 11 (27.5%), 13 (32.5%), and 11 (27.5%), respectively. EBV DNA was detected in the blood of 30 patients (75.0%). In the NGS analysis, mutations involving the JAK/STAT pathway were the most common (n = 17, 42.5%), followed by epigenetic modifier (n = 12, 30.3%), NF-κB pathway (n = 11, 27.5%), tumor suppressor (n = 10, 25.5%), and RAS/MAPK pathway (n = 9, 22.5%). Among these, alterations involving tumor suppressor (P = 0.022) and RAS/MAPK pathway (P = 0.008) were statistically significant poor prognostic factors. Tumor suppressor gene mutations were statistically significantly related to stage III-IV (P = 0.006), distant lymph node involvement (P = 0.002), and prognostic index for natural killer cell lymphoma-EBV (PINK-E) high risk group (P = 0.017). However, alterations involving RAS/MAPK pathway did not significantly correlated with PINK-E or its components. Alterations involving tumor suppressor genes and RAS/MAPK pathway are associated with poor prognosis in ENKTL patients. Tumor suppressor gene mutations are generally correlated with previously known risk factors; however, RAS/MAPK pathway alterations are not.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, #81, Irown-ro, Gangnam-gu, Seoul, 06351, Korea.
- Division of Hematology and Oncology, Department of Internal Medicine, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Department of Pathology, Samsung Medical Center, Sungkyunkwan University School of Medicine, #81, Irown-ro, Gangnam-gu, Seoul, 06351, Korea. jununius@naver.com.
Zitieren
APA
Lee, J., Yoon, S. E., Kim, S. J., Kim, W. S., & Cho, J. (2024). Mutational characteristics of extranodal NK/T-cell lymphoma analyzed in relation to clinical prognostic indices. Annals of Hematology. https://doi.org/10.1007/s00277-024-06035-w
Vancouver
Lee J, Yoon SE, Kim SJ, Kim WS, Cho J. Mutational characteristics of extranodal NK/T-cell lymphoma analyzed in relation to clinical prognostic indices. Annals of Hematology. 2024. doi:10.1007/s00277-024-06035-w
BibTeX
@article{Lee2024,
author = {Lee, Jiyeon and Yoon, Sang Eun and Kim, Seok Jin and Kim, Won Seog and Cho, Junhun},
title = {Mutational characteristics of extranodal NK/T-cell lymphoma analyzed in relation to clinical prognostic indices},
journal = {Annals of Hematology},
year = {2024},
doi = {10.1007/s00277-024-06035-w}
}
EUVIMED